MIAMI, FL, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- Pirani announced the release of the 2026 Latin America ...

NEWARK, DE, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Leclercq American Capital LLC, a US-based private ...

Deep learning is increasingly used in financial modeling, but its lack of transparency raises risks. Using the well-known Heston option pricing model as a benchmark, researchers show that global ...

While most investors remain trapped in the psychological struggle between fear and greed, Professor Alexander James Moore has chosen a fundamentally different path: ending the era of emotional ...

InstantGMP Named #1 for EBR, LIMS & MES Integration Being recognized by Root Analysis as the number one provider of ...

Inflationary pressures may resemble those of the late 1990s and early 2000s. The US economy is experiencing rapid growth, potentially leading to significant fiscal stimulus. Tax collections are a ...

MiaRec Featured as Core Performing Vendor on the CMP Research Prism for Automated QA/QM Showcasing Capability in ...

Parkinson’s disease may begin reshaping the body’s chemistry years before the first tremor or stiffness appears. A growing ...

Introduction Prescription digital therapeutics (PDTx) represent an emerging frontier in healthcare, leveraging software-based solutions to treat or manage specific medical conditions. However, despite ...

Celestica (CLS) stock rated Hold after a 2–3x rally; strong AI networking-driven growth but limited PE upside and 2027 uncertainty. Read more macro analysis here.

DTD has outperformed the S&P 500 YTD, benefiting from rotation into value and dividend-paying stocks. Find out why DTD ETF remains a buy.

In a previous press release dated 15 September 2025 [6], Crosetto had noted: ‘Most grants focus on recruitment and training ($2–5 million over five years). The High-Impact/High-Risk Research Awards ...